Delivery Order SPE2DR25D7066-SPE2DR26F7ZTU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,357.45 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency (DLA) awarded a $12,415.02 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,596.64 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 31, 2025. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,431.73 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 17, 2025. This competitive award, issued on December 16, 2025, involves firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,866.60 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of April 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,437.38 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed-price contract. The award was competitively procured without set-aside provisions and is scheduled for completion by June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,716.25 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed price contract. This non-set-aside competitive award was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $12,357.75 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of December 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,636.79 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,652.37 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 9, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZTUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,576.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of January 12, 2026. This is a firm fixed-price delivery order issued without set-aside designation, meaning it was competitively awarded to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. The place of performance is listed as Conshohocken, PA. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031. This IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current order reflects the company's ongoing role as a critical vendor for federal military and healthcare system pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/10/26 |